Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: A clinicopathological molecular analysis of 121 patients

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1560-1566

  Sokoloff, Mitchell H ^b   Tso, Cho Lea ^b   Kaboo, Randhir ^b   Nelson, Scott ^b   Ko, Judy ^b   Dorey, Frederick ^b   Figlin, Robert A ^b   Pang, Shen ^b   Dekernion, Jean ^b   Belldegrun, Arie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

neoplasm staging; polymerase chain reaction; prostate specific antigen; prostatic neoplasms

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUTORADIOGRAPHY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0343599813     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65447-8     Document Type: Article

References (36)

1. Stamey, T. A. and McNeal, J. E.: Adenocarcinoma of the prostate. In: Campbell's Urology, 6th ed. Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughan, Jr. Philadelphia: W. B. Saunders Co., vol. 2, pp. 1159-1221, 1992.
2. Lu-Yao, G. L. and Greenberg, E. R.: Changes in prostate cancer incidence and treatment in USA. Lancet, 343: 251, 1994.
3. Paulson, D. F., Moul, J. W. and Walther, P. J.: Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J. Urol., 144: 1180, 1990.
4. Paulson, D. F.: Treatment of localized carcinoma of the prostate (clinical stages A and B). In: Prostate Diseases. Edited by H. Lepor and R. K. Lawson. Philadelphia: W. B. Saunders Co., chapt. 29, pp. 368-377, 1993.
5. Schellhammer, P. F.: Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology, 31: 191, 1988.
6. Lerner, S. P., Seale-Hawkins, C., Carlton, C. E., Jr. and Scardino, P. T.: The risk of dying of prostate cancer in patients with clinically localized disease. J. Urol., 146: 1040, 1991.
7. Catalona, W. J. and Dresner, S. M.: Nerve-sparing radical prostatectomy: extraprostatic tumor extension and preservation of erectile function. J. Urol., 134: 1149, 1985.
8. Lu-Yao, G., McLarran, D., Wasson, J. and Wennberg, J.: Aa assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. J.A.M.A., 269: 2633, 1993.
9. Voges, G. E., McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer, 69: 520, 1992.
10. van den Ouden, D., Davidson, P. J. T., Hop, W. and Schröder, F. H.: Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J. Urol., 151: 646, 1994.
11. McCarthy, J. F., Catalona, W. J. and Hudson, M. A.: Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. J. Urol., 151: 1575, 1994.
12. Ekman, P.: Dilemma of microscopic lymph node metastases in human prostate cancer. Eur. Urol., suppl. 2, 24: 57, 1993.
13. Monda, J. M., Barry, M. J. and Oesterling, J. E.: Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia. J. Urol., 151: 1291, 1994.
14. Crawford, E. D. and DeAntoni, E. P.: PSA as a screening test for prostate cancer. Urol. Clin. N. Amer., 20: 637, 1993.
15. Ploch, N. R. and Brawer, M. K.: How to use prostate-specific antigen as a tumor marker. Eur. Urol., suppl. 2, 24: 6, 1993.
16. Wirth, M.: Value of prostate specific antigen as a tumor marker. Eur. Urol., suppl. 2, 24: 6, 1993.
17. Hamdy, F. C., Lawry, J., Anderson, J. B., Parsons, M. A., Rees, R. C. and Williams, J. L.: Circulating prostate specific antigen positive cells correlate with metastatic prostate cancer. Brit. J. Urol., 69: 392, 1992.
18. Wu, A., Ben-Eyra, J. and Columbero, A.: Detection of micrometastases in breast cancer by PCR. Lab. Invest., 62:109A, 1990.
19. Miyamura, N., Tanimoto, M., Morishima, Y., Horibe, K., Yamamoto, K., Akatsuka, M., Kodera, Y., Kojima, S., Matsuyama, K. and Hirabayashi, N.: Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: possible eradication of minimal residual disease by marrow transplantation. Blood, 79: 1366, 1992.
20. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G. and Gomella, L. G.: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110, 1992.
21. Katz, A. E., Olsson, C. A., Raffo, A., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C. and Buttyan, R.: Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765, 1994.
22. Ghossein, R. A., Scher, H. I., Gerald, W. L., Kelly, W. K., Curley, T., Amsterdam, A., Zhang, Z. F. and Rosai, J.: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13: 1195, 1995.
23. Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H. V. and Chen, I. S.: High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature, 343: 85, 1990.
24. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, chapt. 9, pp. 171-198, 1977.
25. American Joint Committee on Cancer: Manual for Staging of Cancer. Philadelphia: J. B. Lippincott Co., 1988.
26. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
27. Katz, A. E., de Vries, G. M., Begg, M. D., Raffo, A. G., Cama, C., O'Toole, K., Buttyan, R., Benson, M. C. and Olsson, C. A.: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75: 1642, 1995.
28. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T. and Wise, G. J.: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306, 1994.
29. Wood, D. P., Jr., Banks, E. R., Humphreys, S., McRoberts, J. W. and Rangnekar, V. M.: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74: 2533, 1994.
30. Bretton, P. R., Melamed, M. R., Fair, W. R. and Cote, R. J.: Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate, 25: 108, 1994.
31. Mansi, J. L., Easton, D., Berger, J., Gazet, J. C., Ford, H. T., Dearnaley, D. and Coombes, R. C.: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur. J. Cancer, 27: 1552, 1991.
32. Seiden, M. V., Kantoff, P. W., Krithivas, K., Propert, K., Bryant, M., Haltom, E., Gaynes, L., Kaplan, L, Bubley, G. and DeWolf, W.: Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 12: 2634, 1994.
33. Liotta, L. A., Kleinerman, J. and Saidel, G. M.: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res., 34: 997, 1974.
34. Epstein, J. I., Cannichael, M. J., Pizov, G. and Walsh, P. C.: Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term follow-up. J. Urol., 150: 135, 1993.
35. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C. and Katz, A. E.: Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373, 1995.
36. Su, S. L., Huang, I. P., Fair, W. R., Powell, C. T. and Heston, W. D.: Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441, 1995.